medRxivGenetic & Genomic MedicinePreprint
Harnessing Mondo and the ILAE Classification for Curation and Analysis of 71,942 epilepsy patient variants
Alina IvaniukiD, Tobias Brünger, Eduardo Pérez‐PalmaiD, Junhui Xiao, Mark St John, Fábio Augusto NascimentoiD, Guo‐Qiang ZhangiD, Samden D. LhatooiD, Dennis LaliD
Abstract
Mapping epilepsy variants in ClinVar to standard disease classifications remains challenging due to incomplete phenotype information. We integrated the Mondo Disease Ontology (Mondo) with the International League Against Epilepsy (ILAE) Classification to systematically identify, organize, and analyze age-dependent epilepsy-associated variants from the worlds largest public variant repository. Starting from over three million ClinVar entries, we filtered monogenic disorders tagged with 421 Mondo terms representing neonatal/infantile, childhood, or variable-onset epilepsy syndromes. Gene-disease validity was further refined using multiple expert-curated lists, resulting in 71,942 unique variant submissions in 171 genes. Approximately 70% of pathogenic and uncertain variants clustered in 50 genes, highlighting the concentration of clinically relevant findings in a relatively small subset of known epilepsy genes. SCN1A, GRIN2A, and DEPDC5 stood out as top contributors to neonatal/infantile, childhood, and variable-onset syndromes, respectively. Notably, two-thirds of genes were specific to a single age group, but the remaining one-third spanned multiple syndromes, reflecting both phenotypic and genetic heterogeneity. We also observed substantial overlap with neurodevelopmental and autism-related genes, especially among early-onset epilepsies, emphasizing shared molecular pathways. Our Mondo-driven approach demonstrates the feasibility of large-scale, ontology-based curation of ClinVar for domain-specific analyses, offering greater clinical precision than traditional text-based queries. This resource can guide epilepsy-focused gene panel design, inform new classification updates, and pave the way for age-targeted therapeutics. By bridging the gap between extensive genomic repositories and detailed clinical ontologies, we provide a robust, standardized framework to accelerate progress in precision epilepsy genetics.
- organism: human
- assay: GWAS summary statistics
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Clinical signatures of genetic epilepsy precede diagnosis in electronic medical records of 32,000 individuals
Peter D. Galer, Shridhar Parthasarathy, … Ingo Helbig·Genetics in MedicinePeer-reviewed·Jul 14, 2024
- Systematic re-annotation of 191 genes associated with early-onset epilepsy unmasks de novo variants linked to Dravet syndrome in novel SCN1A exons
Charles A. Steward, Jolien Roovers, … Adam Frankish·bioRxiv·May 30, 2019
- Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy
Henrike Heyne, Mykyta Artomov, … Johannes R. Lemke·Genetics in MedicinePeer-reviewed·May 6, 2019
- De novo Variants In Neurodevelopmental Disorders With Epilepsy
Henrike Heyne, Tarjinder Singh, … Johannes R. Lemke·Nature GeneticsPeer-reviewed·Jun 22, 2018
- Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes
Epi25 Collaborative, Siwei Chen, … Alica M. Goldman·Nature NeurosciencePeer-reviewed·Oct 1, 2024
- Ultra-rare constrained missense variants in the epilepsies: Shared and specific enrichment patterns in neuronal gene-sets
Mahmoud Koko, Roland Krause, … Christian Hengsbach·EBioMedicinePeer-reviewed·Sep 24, 2021